Serine Octamer Clusters Direct the Chirality of Peptides Formed in Water Microdroplets

22 January 2025, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

The chemistry underlying biological homochirality remains challenging. We propose that non-covalent clusters may have served as the means through which homochiral biochemistry emerged. Serine has long been known to exhibit a chiral preference in clustering to form the octamer; we extend this finding by reporting the effects of a non-zero e.e. in serine on the chiral preference seen in the formation of non-covalent clusters with other amino acids and in the formation of their covalent condensation products, peptides. We show (i) enantiopure serine directs racemic leucine and proline toward enantioselective dipeptide formation in water microdroplets and (ii) likely intermediates are seen as amino acid substitution products into the serine octamer cluster. This work indicates the relevance of microdroplet sprays, such as those found in natural aerosols, to molecular clustering phenomena and to homochirality.

Supplementary materials

Title
Description
Actions
Title
Supporting information
Description
S1: Operational parameters used in tandem MS analysis 2 S2: High resolution MS (HRMS) analysis of ProLeu/LeuPro 3 S3: Hypothesis testing and error analysis 4 S4. Serine octamer observed in experimental conditions of peptide formation 5 S5: Relative abundance of diproline and dileucine formed from solutions 1-3 6 S6: Results of experiments without isotopically labeled Leu 7 S7: Suggestion as to how monomeric excess accumulated in oligomers and primed homochirogenesis.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.